Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel H Giles

Showing results (71-80 of 129) with videos related to

Pageof 13
Sort By:
European Urology|October 17, 2022
A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines PanelUmberto Capitanio, Jens Bedke, Laurence Albiges, et al.
FEBS Letters|January 7, 2004
Fibronectin is a hypoxia-independent target of the tumor suppressor VHLHans A R Bluyssen, Martijn P J K Lolkema, Moniek van Beest, et al.
European Urology Oncology|September 26, 2024
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future DirectionsLaura Marandino, Riccardo Campi, Daniele Amparore, et al.
European Urology|December 11, 2017
Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal CancerThomas Powles, Laurence Albiges, Michael Staehler, et al.
Journal of Proteomics|August 3, 2018
Changes in the urinary extracellular vesicle proteome are associated with nephronophthisis-related ciliopathiesMarijn F Stokman, Irene V Bijnsdorp, Tim Schelfhorst, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2014
Murine Joubert syndrome reveals Hedgehog signaling defects as a potential therapeutic target for nephronophthisisAnn Marie Hynes, Rachel H Giles, Shalabh Srivastava, et al.
European Urology|December 16, 2022
Reply to Yaxiong Tang, Xu Hu, Kan Wu, Yanxiang Shao, and Xiang Li's Letter to the Editor re: Umberto Capitanio, Jens Bedke, Laurence Albiges, et al. A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. Eur Urol. 2022;83:3-5Umberto Capitanio, Jens Bedke, Laurence Albiges, et al.
Journal of the American Society of Nephrology : JASN|April 12, 2014
Renal-retinal ciliopathy gene Sdccag8 regulates DNA damage response signalingRannar Airik, Gisela G Slaats, Zhi Guo, et al.
European Urology|December 18, 2021
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell CarcinomaJens Bedke, Laurence Albiges, Umberto Capitanio, et al.
European Urology|December 28, 2020
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell CarcinomaJens Bedke, Laurence Albiges, Umberto Capitanio, et al.
Pageof 13

Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
European Urology|October 17, 2022
A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines PanelUmberto Capitanio, Jens Bedke, Laurence Albiges, et al.
FEBS Letters|January 7, 2004
Fibronectin is a hypoxia-independent target of the tumor suppressor VHLHans A R Bluyssen, Martijn P J K Lolkema, Moniek van Beest, et al.
European Urology Oncology|September 26, 2024
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future DirectionsLaura Marandino, Riccardo Campi, Daniele Amparore, et al.
European Urology|December 11, 2017
Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal CancerThomas Powles, Laurence Albiges, Michael Staehler, et al.
Journal of Proteomics|August 3, 2018
Changes in the urinary extracellular vesicle proteome are associated with nephronophthisis-related ciliopathiesMarijn F Stokman, Irene V Bijnsdorp, Tim Schelfhorst, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2014
Murine Joubert syndrome reveals Hedgehog signaling defects as a potential therapeutic target for nephronophthisisAnn Marie Hynes, Rachel H Giles, Shalabh Srivastava, et al.
European Urology|December 16, 2022
Reply to Yaxiong Tang, Xu Hu, Kan Wu, Yanxiang Shao, and Xiang Li's Letter to the Editor re: Umberto Capitanio, Jens Bedke, Laurence Albiges, et al. A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. Eur Urol. 2022;83:3-5Umberto Capitanio, Jens Bedke, Laurence Albiges, et al.
Journal of the American Society of Nephrology : JASN|April 12, 2014
Renal-retinal ciliopathy gene Sdccag8 regulates DNA damage response signalingRannar Airik, Gisela G Slaats, Zhi Guo, et al.
European Urology|December 18, 2021
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell CarcinomaJens Bedke, Laurence Albiges, Umberto Capitanio, et al.
European Urology|December 28, 2020
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell CarcinomaJens Bedke, Laurence Albiges, Umberto Capitanio, et al.
Pageof 13